Summary:
"These are games that companies play," he said.India capped the prices of cardiac stents because of huge difference between imported stent's landing price and MRP at hospitals. As per section 11B of the DPCO Act , companies can seek special category status. "On Friday, Abbott applied for withdrawal of its Absorb and Alpine stents, stating "eco nomic unsustainability". "As per this provision, the government has powers to revise, both decrease or increase, the price of a drug. Previous generation stents from both companies are widely used across India..